WIM
INAB icon

Westside Investment Management’s IN8bio INAB Stock Holding History

Westside Investment Management’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-67
Closed -$332 – 1298
2025
Q1 		$332 Hold
67
– – ﹤0.01% 954
2024
Q4 		$514 Sell
67
-333
-83% -$2.92K ﹤0.01% 958
2024
Q3 		$3.24K Hold
400
– – ﹤0.01% 837
2024
Q2 		$10.2K Hold
400
– – ﹤0.01% 654
2024
Q1 		$14.2K Sell
400
-83
-17% -$3.13K ﹤0.01% 572
2023
Q4 		$20K Hold
483
– – 0.01% 498
2023
Q3 		$15.1K Sell
483
-42
-8% -$1.57K ﹤0.01% 525
2023
Q2 		$24.3K Buy
+525
New +$32.8K 0.01% 467

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Westside Investment Management's INAB Position: Q2 2025 in Review

Westside Investment Management sold out of IN8bio (INAB) in Q2 2025, closing a stake of 67 shares — an estimated $332 sold.

Westside Investment Management first reported a position in INAB in Q2 2023 and held it in 8 quarters. The position peaked at $24.3K in Q2 2023. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • Westside Investment Management reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • Westside Investment Management sold 67 IN8bio shares in Q2 2025, an estimated $332.
  • Westside Investment Management first reported a position in IN8bio in Q2 2023 and held it in 8 quarters.
  • Westside Investment Management's IN8bio position peaked at $24.3K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on Westside Investment Management's 13F filing for Q2 2025, filed 5 Aug 2025.